ACOG Calls for Routine Cannabis Screening as Use Reaches 7% in Pregnancy – Fertility Plus
Fertility Plus shared a post on LinkedIn:
“Cannabis is linked to higher rates of preterm birth, low birth weight, and neurodevelopmental issues in babies. Many still think it’s safe—it’s not risk-free!
The American College of Obstetricians and Gynecologists (ACOG) now calls for universal screening of all reproductive-aged individuals for cannabis use during prepregnancy, pregnancy, and lactation. This shift responds to rising cannabis use—now up to 7% in pregnancy—amid nationwide legalization. Research confirms increased risks of preterm birth, low birth weight, and neurodevelopmental impacts in exposed infants. Clinicians are urged to use interviews and validated tools, avoiding biologic drug tests that can result in inequitable care. ACOG highlights the need for evidence-based counseling and risk-reduction strategies personalized to each patient.”
Stay updated on all scientific advances in the field of fertility with Fertility News.
-
Mar 21, 2026, 15:00Samantha Butts Shares Personal and Professional Insights in ASRM Close Up
-
Mar 21, 2026, 14:47Scammers Are Targeting ESHRE2026 Attendees – ESHRE
-
Mar 21, 2026, 14:26No Obvious Harm From Prolonged Oocyte Cryostorage – RBMO
-
Mar 21, 2026, 14:13Empowering Change: Health Systems at the Forefront of Ending FGM/C! – FIGO
-
Mar 21, 2026, 09:56Expanded Carrier Screening: Clinical, Ethical, and Psychosocial Perspectives from Ghent – ESHRE
-
Mar 21, 2026, 09:53Impact of Male Obesity on Embryo Development and Miscarriage Risk – Fertility and Sterility
-
Mar 20, 2026, 17:06Christopher Robinson: AJOG Expert Review on Placenta Accreta After Cesarean
-
Mar 20, 2026, 16:53HCG Failure and Trigger Strategies in IVF – Fertility Plus
-
Mar 20, 2026, 16:38Secure Your Early Bird Ticket for RCOG Annual Professional Development Conference – RCOG